Pantoprazol Reiwa Healthcare (Pantoprazole)

Pantoprazol Reiwa Healthcare is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates mucosal healing and reduces recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Peptic ulcer disease: supports ulcer healing and prevents recurrence.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump in its active state, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Pantoprazol Reiwa Healthcare may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased gas production.
• Constipation: infrequent but reported.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels: muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation.
• Liver enzyme elevation: signs of hepatic injury.

Before starting Pantoprazol Reiwa Healthcare, consider the following safety points:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review liver status: monitor if hepatic disease is present.
• Evaluate long‑term use: assess risk of bone fracture and vitamin B12 deficiency.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit analysis.
• Drug interactions: check concomitant medications for potential CYP450 effects.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the plasma concentrations of several co‑administered drugs. Monitoring and dose adjustments may be required.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy.
• HIV protease inhibitors (ritonavir, atazanavir): decreased plasma levels.
• Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR; monitor coagulation.
• Methotrexate: reduced renal clearance; watch for toxicity.
• Digoxin: possible rise in serum concentration.
• Phenytoin: altered metabolism; check therapeutic levels.
• Oral contraceptives: may lower hormone levels; advise backup contraception.